Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244234![]() (US9428501, 58) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.860 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244236![]() (US9428501, 69) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.80 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244233![]() (US9428501, 57) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.80 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244235![]() (US9428501, 66) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.80 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244223![]() (US9428501, 18) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244237![]() (US9428501, 79) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.30 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244226![]() (US9428501, 35) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.60 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244227![]() (US9428501, 36) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.10 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244230![]() (US9428501, 44) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.20 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244231![]() (US9428501, 49) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.5 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244220![]() (US9428501, 7) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.30 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244228![]() (US9428501, 37) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244224![]() (US9428501, 19) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244229![]() (US9428501, 38) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244221![]() (US9428501, 8) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244232![]() (US9428501, 50) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244225![]() (US9428501, 23) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 19 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244219![]() (US9428501, 1) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 24 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
AMPK subunit alpha-2 (Homo sapiens (Human)) | BDBM244222![]() (US9428501, 14) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 34 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328281![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-5-(4-(thioph...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328285![]() (6-(4-(4-cyanophenoxy) piperidine-1-carbonyl)- N-(...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328286![]() (6-(4-(4-methoxybenzoyl) piperidine-1-carbonyl)- N...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328287![]() (6-(4-(4-methoxybenzoyl) piperidine-1-carbonyl)- N...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM409400![]() (N-((3S,4R)-3-fluoro-1-((5-methylisoxazol- 3-yl)met...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328292![]() (6-(4-(4-methoxybenzoyl) piperidine-1-carbonyl)- N...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328295![]() (6-(4-(3-(cyclopropane- carboxamido)phenoxy) piper...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM409408![]() (N-((cis)-4-(4-cyanophenoxy)cyclohexyl)-6- (4-(3- (...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328297![]() (6-(4-(3-(cyclopropane- carboxamido)phenoxy) piper...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328298![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-6-(4-(4- (tr...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328299![]() (6-(4-(4-acetylphenoxy) piperidine-1-carbonyl)- N-...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328300![]() (6-(4-(3-(cyclopropane- carboxamido)phenoxy) piper...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328301![]() (N-(1-(4-methoxybenzyl) piperidin-4-yl)-6-(4-(4- (...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328302![]() (6-(4-(4-(pyrrolidin-1- yl)benzoyl)piperidine-1- ca...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328303![]() (6-(4-(4-(pyrrolidin-1- yl)benzoyl)piperidine-1- ca...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM409416![]() (N-((cis)-4-(4-cyanophenoxy)cyclohexyl)-6- (4-(4-(p...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328305![]() (N-(1-(3-fluoro-4- methoxybenzyl) piperidin-4-yl)-...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328306![]() (6-(4-(4-(pyrrolidin-1- yl)benzoyl)piperidine-1- ca...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328308![]() (N-(1-(4- isopropoxybenzyl) piperidin-4-yl)-6-(4-(...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328309![]() (N-(1-(4-cyano-3- fluorobenzyl)piperidin- 4-yl)-6-(...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328312![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-6-(4-(4- (tr...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM409425![]() (N-((trans)-1-(4-cyanobenzyl)-3- fluoropiperidin-4-...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328314![]() (N-((3R,4R)-1-(4- cyanobenzyl)-3- fluoropiperidin-4...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328315![]() (N-((3S,4S)-1-(4- cyanobenzyl)-3- fluoropiperidin-4...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM409428![]() (N-((cis)-1-(4-cyanobenzyl)-3- fluoropiperidin-4-yl...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328317![]() (6-(4-(4- (cyclopropanecarbonyl) phenoxy)piperidin...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328318![]() (N-(1-(4- cyanobenzyl)piperidin-4- yl)-6-(4- (cyclo...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328319![]() (6-(4-(4- (cyclopropanecarbonyl) phenoxy)piperidin...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328320![]() (6-(4-(4- (cyclopropanecarbonyl) phenoxy)piperidin...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328321![]() (N-(6-(4- cyanophenoxy)pyridin- 3-yl)-6-(4-(4- (met...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM328322![]() (N-(6-(4- cyanophenoxy)pyridin- 3-yl)-6-(4-(4- meth...) | PDB Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US10377742 (2019) BindingDB Entry DOI: 10.7270/Q2RV0R22 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 1139 total ) | Next | Last >> |